Associate Member, Transplantation Program
Clinical Research Division, Fred Hutch
Dr. Bart Scott specializes in treating patients with myelodysplastic syndromes, or MDS, and myeloproliferative neoplasms, or MPN. These are a collection of diseases in which the bone marrow produces either too many or too few mature blood cells. Dr. Scott studies ways to improve treatment strategies for these patients, in particular new combinations of conditioning regimens prior to blood stem cell transplant.
Clinical Director, MDS/MPN and Myeloid Malignancies
Seattle Cancer Care Alliance
Assistant Professor, Oncology
University of Washington School of Medicine
B.S., Biology and Chemistry, University of Alabama at Birmingham, 1991
M.D., University of South Alabama, 1996
Clinical trials for myelodysplastic syndrome and myeloproliferative disorders
Study Number: 2661.00
Study Number: 9422
Study Number: 9782
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.